Literature DB >> 12738343

The Danish PET/depression project: poor verbal fluency performance despite normal prefrontal activation in patients with major depression.

Poul Videbech1, Barbara Ravnkilde, Salomeh Kristensen, Annette Egander, Karin Clemmensen, Niels Anton Rasmussen, Albert Gjedde, Raben Rosenberg.   

Abstract

The verbal fluency (VF) test is associated with prefrontal and cingulate functioning. We used positron emission tomography (PET) to test the hypothesis that inactivity in these regions can explain why patients with depression often perform poorly on this test. Forty-one patients with major depression and 46 controls were scanned during rest and during activation with the VF test. The differences between the two conditions were mapped for each of the two groups, and between-group differences in the activation pattern were calculated on a voxel-by-voxel basis. As predicted, the patients performed significantly more poorly on the test. In both groups activations were seen in the left anterior cingulate region, the left dorsolateral prefrontal cortex, the left medial prefrontal cortex, and the right cerebellum. Performance was correlated to the cerebral perfusion in to the left occipitotemporal gyrus and the left cerebellum. However, no difference in activation between the two groups was significant. The present study had sufficient power to detect potential differences between the two groups, and the subtraction tasks were appropriate. Therefore, the result supports the notion that abnormalities in the prefrontal cortex in depression are qualitative in nature rather than quantitative; this suggests depression involves dys-coordination of neural activity in the frontal lobes rather than a simple reduction in activity.

Entities:  

Mesh:

Year:  2003        PMID: 12738343     DOI: 10.1016/s0925-4927(03)00002-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  [Executive functions in patients with depression. The role of prefrontal activation].

Authors:  N Vasic; R C Wolf; H Walter
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

Review 2.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

3.  Increased neural activity during overt and continuous semantic verbal fluency in major depression: mainly a failure to deactivate.

Authors:  Heidelore Backes; Bruno Dietsche; Arne Nagels; Mirjam Stratmann; Carsten Konrad; Tilo Kircher; Axel Krug
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-21       Impact factor: 5.270

4.  Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women.

Authors:  Rachel H X Wong; Hamish M Evans; Peter R C Howe
Journal:  Alzheimers Dement (N Y)       Date:  2016-08-03

5.  Prefrontal Asymmetry during Cognitive Tasks and its Relationship with Suicide Ideation in Major Depressive Disorder: An fNIRS Study.

Authors:  Seung Yeon Baik; Jeong-Youn Kim; Jongkwan Choi; Ji Yeong Baek; Yeonsoo Park; Yourim Kim; Minjee Jung; Seung-Hwan Lee
Journal:  Diagnostics (Basel)       Date:  2019-11-15

6.  Variation in Thyroid-Stimulating Hormone and Cognitive Disorders in Unmedicated Middle-Aged Patients with Major Depressive Disorder: A Proton Magnetic Resonance Spectroscopy Study.

Authors:  Hui Zhao; Shunkai Lai; Shuming Zhong; Yiliang Zhang; Hui Yang; Yanbin Jia
Journal:  Mediators Inflamm       Date:  2022-09-05       Impact factor: 4.529

7.  Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research.

Authors:  Diane Sliz; Shawn Hayley
Journal:  Front Hum Neurosci       Date:  2012-12-03       Impact factor: 3.169

8.  The Relationship between Negative Affect and Reported Cognitive Failures.

Authors:  Tabitha W Payne; Michael A Schnapp
Journal:  Depress Res Treat       Date:  2014-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.